welcome
Reuters

Reuters

Health

Health

Prices for new US drugs doubled in 4 years as focus on rare disease grows

Reuters
Summary
Nutrition label

87% Informative

Prices for newly-launched pharmaceuticals more than doubled last year compared to 2021 .

Increase in prices has occurred even as the U.S. government tries to rein in prescription costs.

Percentage of drugs launched for rare diseases rose to 72% in 2024 from 51% in 2019 .

Highest price for a drug taken consistently was over $1 million for Niemann -pick disease type C.

VR Score

94

Informative language

99

Neutral language

62

Article tone

formal

Language

English

Language complexity

57

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links